Dr. Laura Quan man Chow MD
Oncologist | Medical Oncology
825 Eastlake Ave E Seattle WA, 98109About
Dr. Laura Chow is an oncologist practicing in Seattle, WA. Dr. Chow specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Chow manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
- Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
- EGFR mutations in squamous cell lung cancer in never-smokers.
- Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland.
- Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.
- A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736.
- The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
- Harnessing the Immune System as a Therapeutic Tool in Virus-Associated Cancers.
- Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
- The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy.
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Dr. Laura Quan man Chow MD's Practice location
Dr. Laura Quan man Chow MD's reviews
Write ReviewPatient Experience with Dr. Chow
- Anonymous
a very careful honest caring doctor.
- Anonymous
Dr. Chow Rating.
Recommended Articles
- Three Women in One Family Battle Breast Cancer Together
Genetics are a risk factor that no one can avoid when it comes to having a higher risk of disease. Genes passed down from parents inform the way that every cell grows and behaves.Breast cancer is one of the diseases that has a hereditary risk factor. It is estimated that between 5% and 10% of all...
- What Causes Bladder Cancer?
What Causes Bladder Cancer?Bladder cancer a common type of cancer that usually begins in the cells lining your bladder, which is also referred to as the transitional epithelium. Just as the other types of cancer, bladder cancer develops into a life-threatening condition. However, 50% of its cases...
- What Are the Symptoms of Testicular Cancer?
Testicular cancer is rare when compared to other forms of cancer. This cancer develops in one or both testicles in men, particularly among men in the between the ages of 20-years-old and 40-years-old. It may be seen in elderly men as well. In the past few decades, the number of people affected by...
- Finding Breast Cancer's Hiding Place: A New Study
Scientists have often wondered why some patients respond so well to chemotherapy and why some don’t. Some cancers are easier to cure while others have a higher risk of relapse and continued issues. Each cancer is different and every cancer treatment is tailored to the cancer cells it’s...
- Tumor DNA in Blood Used to Spot Ovarian Cancer
The longer that a cancerous tumor lies undetected in the body, the greater the risk of severe or irreversible complications. That being said, detecting cancer early can be difficult, especially if the cancer shares symptoms with other, more common diseases. Many cancers have high survival rates in...
- Nipple-Sparing Mastectomy Proves to Have Low Risk of Cancer Recurrence
One breast cancer treatment choice that has gained some traction in terms of preventing cancer recurrence is the nipple-sparing mastectomy. What is a nipple-sparing mastectomy? How does it differ from a regular mastectomy? For many, getting invasive treatment for breast cancer is intimidating,...
Nearby Providers
- Dr. Stephen H. Culp M.D.1959 Ne Pacific St Seattle WA 98195
- Nick N. Chen200 Andover Park East Tukwila Washington 98188
- Paul E. NeimanPO Box 19024 Seattle Washington 98109
- Dr. Herschel D Wallen M.D.2722 Ne Blakeley St Seattle WA 98105
- Dr. Steven S. Ginsberg M.D.825 EASTLAKE AVE E SEATTLE WA 98109
- Hannah M Linden OtherHarborview Medical Center Seattle WA 98104